Board of Directors

Brent has over 25 years of experience in various aspects of healthcare and has been in leadership roles at several prominent global pharmaceutical and healthcare companies. Until May 2020, when it was acquired by AbbVie Inc. in a transaction valued at approximately $63 billion, Brent served as Chairman, President and Chief Executive Officer of Allergan plc. His role as President and Chief Executive Officer of Allergan began in July 2014 and his added role of Chairman began in October 2016. Brent’s first role as an executive officer in the pharmaceuticals and healthcare sectors began in 2003, as a member of the executive management team at Schering-Plough Corporation, where he held several key roles, including President of the company’s Global Consumer Health Care division. While at Schering-Plough, Brent led the integrations of the company’s $14 billion acquisition of Organon Biosciences N.V in 2007 as well as the merger between Schering-Plough and Merck & Co., Inc. in 2009. From March 2010 until August 2013, Brent served as Chief Executive Officer of Bausch + Lomb Incorporated, a leading global eye health company, until its acquisition by Valeant Pharmaceuticals, Inc. in 2013. He then became the Chief Executive Officer of Forest Laboratories Inc., a role he held until the company’s merger with Actavis plc in 2014. Following the merger with Actavis, Brent was named Chief Executive Officer of the combined business. In 2015, he led Actavis’ acquisition of Allergan, renaming the combined company Allergan Plc.

Before joining Schering-Plough in 2003, Brent was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was Chief Risk Officer at Coventry Health Care, Inc. and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporation of America. Brent began his career as Chief Compliance Officer for the Thomas Jefferson University Health System.

Brent currently serves as Chairman and CEO of Bausch + Lomb Corporation.

Pedro Malha is President and Chief Executive Officer of BeautyHealth. He brings more than two decades of global leadership in the healthcare and medical device industries, where he has consistently delivered growth, operational excellence, and built collaborative, high-performing teams.

He most recently served as Worldwide Division President and Corporate Officer of Abbott Laboratories, where he led the neuromodulation business. Prior to that, he held senior leadership roles overseeing multiple global business units at Zimmer Biomet Holdings, Abbott, and Johnson & Johnson, consistently delivering growth and operational excellence.

Mr. Malha holds an MBA from Boston University and a Bachelor of Science from Bentley University.

Stephen J. Fanning is a medical aesthetics veteran with extensive industry knowledge and proven success in driving global growth.

Mr. Fanning brings decades of global medical aesthetics experience, including serving as Hydrafacial’s Chairman of the Board from 2016 to 2020, prior to the Company’s initial public offering. He was recently the President and Chief Executive Officer of Spectrum Solutions, a molecular diagnostics firm, and previously led Z-Medica, boosting sales and EBITDA before its acquisition by Linden Capital. Mr. Fanning also headed Solta Medical, known for Thermage and Fraxel, and held leadership roles at Ocular Sciences and Johnson & Johnson, driving international growth.

He currently serves as Chairman of the Board for Champion Manufacturing and LKC Technologies.

Mr. Fanning holds a Bachelor of Science degree from Philadelphia University.

Peabody Award-winner Desiree Gruber founded Full Picture, a brand accelerator, content production, communications, and consulting services company now in its 21st year, with a passion to help her clients more effectively tell their stories and launch new ideas into the world. Gruber continues to evolve her mission of shaping zeitgeist-defining moments and reimagining how brands delight and engage global audiences in her work as an entrepreneur, business strategist, and venture capitalist.

Through Diagonal Ventures (DGNL), Gruber has embraced a preeminent role in developing and supporting female founders and C-suite executives. With a goal of creating real opportunities for women to achieve measurable success, DGNL invests in and architects transformational deals across the consumer, technology, and media spectrum in order to establish a legacy of female empowerment.

Among Gruber’s many accomplishments to date is co-founding the Project Runway television series. In addition to her Peabody Award, as executive producer of the groundbreaking show for 16 seasons she received a GLAAD Media Award and earned 14 Emmy nominations.

A lifelong advocate for a more equitable and inclusive world, she proudly serves on the boards of UNICEF USA, Tech:NYC, and God's Love We Deliver, and was the recipient of UNICEF’s 2018 Spirit of Compassion Award. She is also an advisor to leading organizations such as Anthos Capital, Pharrell Williams’ Something in the Water, and Chegg.

Gruber lives with her husband, Kyle MacLachlan, and their son.

Michelle Kerrick is an accomplished leader and retired “Big 4” accounting firm partner with 35 years of diverse management and executive leadership experience, with Deloitte. She currently serves on the boards of the publicly traded REIT, American Homes 4 Rent (NYSE: AMH), Beauty Health (SKIN) and Capital Bank & Trust Company (a subsidiary of Capital Group) and formerly served SoftBank’s LDH Growth Corp I (LDHAU).

Michelle has been a trusted advisor to Fortune 500 C-suite executives, corporate boards and audit committees across a broad set of industries including real estate/REITs, consumer products and technology. She brings experience in the areas of financial and strategic planning, operational effectiveness and digital transformation. She also has a strong background in corporate governance and is qualified to serve as a financial expert.

Michelle served as the West Region Market Leader and Managing Partner of the Los Angeles office of Deloitte, the world’s largest professional services firm. As one of three regional leaders in the U.S., Michelle helped drive national strategy, client and business growth, and strategic positioning across the region, which included 13 offices in eight states, and over 9,000 people. Under her leadership the region grew to over $3 billion in annual revenues and was consistently the fastest growing region in the U.S. Firm. As the leader of the Los Angeles practice, which employed more than 2,200 audit, tax, consulting, and financial advisory services professionals, the practice grew by more than 50% and attained revenues in excess of $450 million.

Michelle began her career with Deloitte in the Phoenix office in the Audit group in 1985. She became a Partner of the Firm in 1998 and Managing Partner of the Phoenix Office in 2005. She transferred to Los Angeles as the Managing Partner in late 2010 and became the West Region Market Leader in 2019. Michelle advised a diverse group of public and privately held companies ranging from middle market to large multi-nationals and now serves as a board member to public and private/pre-IPO companies.

As a relationship leader and financial expert, Michelle led the Firm’s National CFO Leadership Program for the West Region which focused on supporting CFOs in their complex roles. Michelle led the relationships with strategic Deloitte client’s including Mattel, the Los Angeles Sports and Entertainment District (Sofi Stadium), CBRE and Snap Inc. During her career she gained extensive experience in the boardroom working with the Audit Committees and Boards of companies including Mattel, Teledyne, Taylor Morrison, Kilroy Realty and TCW Group on a range of complex issues, including digital transformation, IPOs, cost reduction, cybersecurity, governance and enterprise risk.

Michelle has deep experience in governance roles within Deloitte. She served on Deloitte’s Board Council and Strategic Investment Committee in which she oversaw various acquisitions and investments. Michelle also served two terms on Deloitte’s Nominating Committee which is responsible for CEO and board director selection. Michelle attends various board governance programs and completed the Harvard Business School Making Corporate Boards More Effective program in November 2024.

As a community leader, Michelle held a number of senior governance roles in prominent professional and community organizations. She served as the 2018 Board Chair of the Los Angeles Chamber of Commerce; board member of Los Angeles Sports and Entertainment Commission; Board of Advisors for Salvation Army Western Territories; a member Young President’s Organization Los Angeles Gold; and a Director of Polytechnic School in Pasadena. She was also on the Bid Committees which secured the 2022 Super Bowl, as well as the 2028 Olympic Summer Games for Los Angeles.

She is committed to the advancement of women in the workplace. Michelle was named a Los Angeles Top 500 Leader, “Executive of the Year,” as well as, one of the “Most Influential Women in Accounting” by the Los Angeles Business Journal.

Michelle received her B.S. degree in accountancy from Northern Arizona University and is a recipient of the University’s outstanding alumnus award. Michelle is a Retired member of the California and Arizona State Boards of Accountancy, and the American Institute of Certified Public Accountants.

Brian Miller is a Managing Partner and Co-Founder of Linden Capital Partners. He has been involved in healthcare principal investing since 1998. Prior to Linden, Brian was a founding member of the healthcare team at First Chicago Equity Capital. Mr. Miller began his career in the investment banking division of Salomon Brothers Inc. (currently Citigroup). He is currently a board member of Beauty Health Co., MeriCal, Collagen Matrix, Vital Care, StatLab, and Formulated Solutions, and was previously a board member of Flexan, Z-Medica, Solara, SeraCare, BarrierSafe Solutions International, CORPAK MedSystems, HYCOR Biomedical, Strata Pathology Services and Suture Express.

Mr. Miller holds a Bachelor of Arts with honors in Economics from Princeton University and an MBA from Harvard Business School, with a concentration in healthcare. He is a board member of AdvaMed, the Founder of the Healthcare Private Equity Association, the founder of Private Equity Analysts of Chicago, a Trustee of The University of Chicago Medical Center, and a member of the Economic Club of Chicago.

Dr. Philippe Schaison is a CEO, Global President and Chief Commercial Officer in biotech, consumer healthcare, consumer goods and retail sectors (NA, Asia, South America and Europe). His experience includes running a $2.5B+ business growing 17% a year at Allergan, acquiring and integrating +$2B organization, and leading global organizations to implement successful operations and drive profitability. His strong communication and interpersonal skills, and his ability to work effectively with boards and senior executives and build/lead high-performance teams has informed much of his work.

Dr. Schaison is a board member of multiple early stage and commercial ready biotech and aesthetic companies helping with their effort to raise money, go to market plans and exit strategy. In 2024 he sold Sientra and Revelle aesthetic to Tigers bioscience. He is the chairman of the board of Raziel therapeutics an Israeli based biotech developing a fat melting injectable currently in Phase III. Dr. Schaison is on the board of Forefront a PE owned dermatology rollup company with revenues exceeding $1B. He is also on the board of Aivita, Miradry, Dyve and Sofregen.

For the last 4 years Dr. Schaison has been the CEO of Soltégo® and early stage bio-cosmetic startup developing a Harvard innovation for DNA repair and melanogenesis.

Prior to Soltégo® he has been hired by the Chairman and Board of Directors of Syneron-Candela to take a publicly traded company (ELOS) private, Dr. Schaison sold the company to Private Equity firm Apax in July 2017 for $11 a share; a two-fold increase over past trading value. He identified potential acquirers, worked with Barclays Bank to develop Management Presentation, developed with Senior Leadership Team material for Due Diligence, and restructured the North America Commercial Team.

Earlier, serving as President of Allergan US Aesthetic and Dermatology, Dr. Schaison reported to the CEO, was a member of the Allergan Executive Leadership Team, and led the Facial Aesthetic, Plastic and MedDerm/Skin Medica business unit, an organization of 2000+ professionals. He secured market leadership for every single product by leading a sophisticated, two-pronged model (B2B and B2C) that enabled the organic growth of the $2.5B business by 17% a year. He also solidified a one-stop shopping approach with the $2.1B acquisition of Kythera. Leading a self-sustaining internal advertising agency providing internal/external services, he has optimized advertising cost efficiencies and increased effectiveness by leveraging the agency’s proximity to business, expertise, and stability.

Before joining Allergan, Dr. Schaison served as President, World Wide Travel Retail & Regional President, LATAM and MEA, at Clarins in New York (2010 – 2013). Reporting to the CEO, he was responsible for a $1B+ retail sales business. Leading an organization of 3000+ professionals, he generated 55% of Clarins’ total net sales and 70% of its EBIT, achieving double-digit growth in a single digit market (+28%).

Earlier, Dr. Schaison served as CEO for Aesthetic Factors (2008 – 2010), a manufacturer of point-of-care systems for regenerative medicines.

From 2003 to 2008, Dr. Schaison served as Vice President of Global Skin Care for Johnson & Johnson, with P&L responsibility for Aveeno, Clean & Clear, Lubriderm and Ambi international markets, consistently exceeding financial business plan objectives. Launching Aveeno into new markets (Russia, France, UK, Latin America, and Asia), he captured a top 3 ranking. As Board Member of Ortho- Neutrogena, he enabled the entrance into the booming aesthetic market by recommending Colbar’s acquisition ($150M).

Before joining Johnson & Johnson, Dr. Schaison worked in executive positions at L'Oréal (1997 – 2003). He built a new division in charge of all dermo-cosmetic brands from the ground-up; and prepared the U.S. launch of Vichy, the number one skin care brand in Europe in the Pharmacy channel, and La Roche Posay. In a visionary move, he created a new business model (store within a store concept) by moving brands previously limited to physicians-only distribution to being sold in high-growth US drugstores.

Dr. Schaison started his professional career at Merck & Company as a Group Manager in Paris.

He earned an MBA (Marketing) from the Hautes Etudes Commerciales (H.E.C.) in Paris, and a Doctorate in Pharmacy (Industrial) from the University of Paris V. A dual US and French citizen, and a co world champion of 1000x100m freestyle swimming relay, he enjoys competitive skiing, scuba diving, marathons and paragliding, and has a Black belt second Dan in Tae Kwon Do. He is also a commercial single and multi-engine Pilot and a flight instructor.